Skip to main content
OpenTrials

Clinical trial condition

Hyperoxaluria

Explore clinical trials studying Hyperoxaluria. Study availability and eligibility vary by location and protocol.

36 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Hyperoxaluria trial results

Completed

Evaluating ALLN-177 for Reducing Urinary Oxalate Excretion in Calcium Oxalate Kidney Stone Formers With Hyperoxaluria

NCT02289755

Conditions
Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Indiana University Physicians Urology Indianapolis, Indiana, United States
  • North Shore Long Island Jewish Health System Lake Success, New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Omega Clinical Research Warwick, Rhode Island, United States
View Trial Details
Completed

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones

NCT02503345

Conditions
Calculi, Dietary Hyperoxaluria, Female Urogenital Diseases, +14 more
Locations
  • Tower Urology Los Angeles, California, United States
  • Atlantic Urological Associates Daytona Beach, Florida, United States
  • Mayo Clinic - Nephrology And Hypertension Jacksonville, Florida, United States
  • Northwestern Feinberg School Of Medicine - Urology Department Chicago, Illinois, United States
View all 16 locations
View Trial Details
Completed

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days

NCT02547805

Conditions
Calculi, Dietary Hyperoxaluria, Female Urogenital Diseases, +14 more
Locations
  • Mayo Clinica Arizona Pheonix, Arizona, United States
  • Urological Associates of Southern Arizona, PC Tuscon, Arizona, United States
  • Applied Research Center of Arkansas, Inc. Little Rock, Arkansas, United States
  • South Florida Medical Research, LLC Aventura, Florida, United States
View all 22 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria

NCT02012985

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +12 more
Locations
  • Hôpital Robert-Debré, Néphrologie Pédiatrique Paris, Cedex 19, France
  • Hôpital des Enfants, Centre de référence maladies rénales rares du Sud-Ouest (SORARE), CHU de Bordeaux Bordeaux, France
  • Hôpital Femme Mère Enfant, Lyon - Paediatric Dept Lyon, France
  • Hôpital Necker-Enfants Malades,Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA) Paris, France
View Trial Details
Completed

Phase 2/3 Oxabact Study

NCT01037231

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +12 more
Locations
  • Mayo Clinic (Department of Pediatric Nephrology) Rochester, Minnesota, United States
  • University Children's Hospital (Division of Pediatric Nephrology) Cologne, Germany
  • Academy Medical Center, University of Amsterdam Amsterdam, Netherlands
View Trial Details

Related conditions